Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.

Bolis, G; Favalli, G; Danese, S; Zanaboni, F; Mangili, G; Scarabelli, C; Tateo, S; Valsecchi, M G; Scarfone, G; Richiardi, G; Frigerio, L; Melpignano, M; Villa, A; Parazzini, F

Bolis, G; Favalli, G; Danese, S; Zanaboni, F; Mangili, G; Scarabelli, C; Tateo, S; Valsecchi, M G; Scarfone, G; Richiardi, G; Frigerio, L; Melpignano, M; Villa, A; Parazzini, F.

Affiliation

Bolis G; I Clinica Ostetrico Ginecologica, Università di Milano, Italy.

J Clin Oncol ; 15(5): 1938-44, 1997 May.

Article in En | MEDLINE | ID: mdl-9164205

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Ovarian Neoplasms/drug therapy; Adult; Aged; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Middle Aged; Multivariate Analysis; Neoplasm Staging; Ovarian Neoplasms/pathology; Ovarian Neoplasms/surgery; Survival Analysis

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Cyclophosphamide Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 1997 Type: Article

Search on Google

XML

PubMed Links